发明名称 |
MONITORING ANTI-ANGIOGENESIS THERAPY |
摘要 |
<p>The present invention relates to a method for monitoring subjects being on anti-angiogenesis therapy based on determining the amount of a cardiac troponin in a first and second sample of a subject and comparing the amount in the first sample with the second sample. Thereby, it can be assessed whether a subject is susceptible to a continuation of the therapy or not. Moreover, the present invention relates to a method for predicting the risk of a cardiovascular event as a consequence of anti-angiogenesis therapy. Also encompassed by the present invention are kits and devices adapted to carry out the method of the present invention.</p> |
申请公布号 |
EP2324358(A1) |
申请公布日期 |
2011.05.25 |
申请号 |
EP20090780991 |
申请日期 |
2009.07.23 |
申请人 |
F. HOFFMANN-LA ROCHE AG;ROCHE DIAGNOSTICS GMBH |
发明人 |
HESS, GEORG;HORSCH, ANDREA;ZDUNEK, DIETMAR |
分类号 |
G01N33/574 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|